WHO monographs on selected medicinal plants - travolekar.ru

WHO monographs on selected medicinal plants - travolekar.ru WHO monographs on selected medicinal plants - travolekar.ru

20.01.2015 Views

ong>WHOong> ong>monographsong> on selected medicinal plants constituent is the isoquinoline alkaloid, magnocurarine (0.15–0.23%). The presence of liriodendrine has also been reported. The bark also contains an essential oil, the major constituents of which are cadinol (14%), 1,4-cineole (6%), p-cymene (8%), and -eudesmol (17%) and geraniol (9%), among others (8, 15–18). The structures of magnolol, honokiol and magnocurarine are presented below. Honokiol H 2 C H 2 C OH OH Magnolol H 2 C HO OH Magnocurarine H CH 3 HO N + CH 3 CH 2 H 3 CO OH Medicinal uses Uses supported by clinical data No information was found. Uses described in pharmacopoeias and well established documents Used orally for the treatment of gastrointestinal disorders such as constipation, dyspepsia, gastritis, nausea and vomiting. Also used orally to treat anxiety, coughs and shortness of breath (2). Uses described in traditional medicine Treatment of allergic rhinitis, headache, lack of appetite, respiratory congestion, neurosis and fever, and as a uterine stimulant (6, 8, 19, 20). Pharmacology Experimental pharmacology Since no clinical studies have directly evaluated Cortex Magnoliae for any therapeutic condition and very few pharmacological studies have been conducted on extracts of the bark, most of this section describes the pharmacology and clinical studies of the major chemical constituents, particularly magnolol. The correlation of these data to the crude drug or its extracts requires further investigation. Anti-allergic activity Oral administration of 0.01–1.0 g/kg body weight (bw) of an aqueous extract of the bark dose-dependently inhibited compound 48/80-induced systemic anaphylaxis in rats (21). At the same dose, the aqueous extract 170

Cortex Magnoliae also significantly inhibited local immunoglobulin E (IgE)-mediated passive cutaneous anaphylactic reaction and reduced the levels of plasma histamine in a dose-dependent manner (p < 0.05). In vitro, the extract (at concentrations of 0.001–1.0 mg/ml) concentration-dependently inhibited the histamine release from rat peritoneal mast cells activated by compound 48/80 or anti-dinitrophenyl IgE (21). Anti-asthmatic activity Magnolol stimulates calcium channel activity in tracheal smooth muscle cells as assessed by the patch clamp technique (22). In whole-cell current recordings, magnolol reversibly increased the amplitude of potassium outward currents. The increase in outward current caused by magnolol was sensitive to inhibition by iberiotoxin (200 nM) or paxilline (1 μM), but not by glibenclamide (10 μM). In inside-out patches, addition of magnolol to the bath did not modify single channel conductance, but effectively enhanced the activity of large conductance calcium (Ca) activated potassium BK (Ca) channels. Magnolol increased the probability of these channel openings in a concentration-dependent manner with a median effective concentration (EC 50 ) value of 1.5 μM. The direct stimulation of these BK (Ca) channels by magnolol may explain the mechanism by which it acts as an anti-asthmatic compound (22). Antibacterial activity An ethanol extract of the bark inhibited the growth of Actinomyces viscosus ATCC 19246, Streptococcus mutans Ingbritt and Streptococcus sobrinus 6715, with a minimum bactericidal concentration of 0.488, 0.488 and 1.250 g/l, respectively (23). The antimicrobial activities of honokiol and magnolol were assayed using the agar dilution method and the minimum inhibitory concentration (MIC) was determined for each compound using a twofold serial dilution assay. The results showed that honokiol and magnolol have a marked antimicrobial effect (MIC, 25.0 μg/ml) against Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, Micrococcus luteus and Bacillus subtilis, but were not active against Shigella flexneii, Staphylococcus epidermidis, Enterobacter aerogenes, Proteus vulgaris, Escherichia coli and Pseudomonas aeruginosa (24). An extract of the bark and magnolol inhibited the growth of Helicobacter pylori in vitro (25). Anti-gastric ulcer activity Intragastric administration of aqueous and methanol extract of the crude drug (400 mg/kg bw) reduced gastric juice secretion and increased the pH of gastric secretions in mice pretreated with indometacin (26). Indometa- 171

Cortex Magnoliae<br />

also significantly inhibited local immunoglobulin E (IgE)-mediated passive<br />

cutaneous anaphylactic reacti<strong>on</strong> and reduced the levels of plasma histamine<br />

in a dose-dependent manner (p < 0.05). In vitro, the extract (at<br />

c<strong>on</strong>centrati<strong>on</strong>s of 0.001–1.0 mg/ml) c<strong>on</strong>centrati<strong>on</strong>-dependently inhibited<br />

the histamine release from rat perit<strong>on</strong>eal mast cells activated by compound<br />

48/80 or anti-dinitrophenyl IgE (21).<br />

Anti-asthmatic activity<br />

Magnolol stimulates calcium channel activity in tracheal smooth muscle<br />

cells as assessed by the patch clamp technique (22). In whole-cell current<br />

recordings, magnolol reversibly increased the amplitude of potassium<br />

outward currents. The increase in outward current caused by magnolol<br />

was sensitive to inhibiti<strong>on</strong> by iberiotoxin (200 nM) or paxilline (1 μM),<br />

but not by glibenclamide (10 μM). In inside-out patches, additi<strong>on</strong> of magnolol<br />

to the bath did not modify single channel c<strong>on</strong>ductance, but effectively<br />

enhanced the activity of large c<strong>on</strong>ductance calcium (Ca) activated<br />

potassium BK (Ca) channels. Magnolol increased the probability of these<br />

channel openings in a c<strong>on</strong>centrati<strong>on</strong>-dependent manner with a median<br />

effective c<strong>on</strong>centrati<strong>on</strong> (EC 50<br />

) value of 1.5 μM. The direct stimulati<strong>on</strong> of<br />

these BK (Ca) channels by magnolol may explain the mechanism by<br />

which it acts as an anti-asthmatic compound (22).<br />

Antibacterial activity<br />

An ethanol extract of the bark inhibited the growth of Actinomyces viscosus<br />

ATCC 19246, Streptococcus mutans Ingbritt and Streptococcus sobrinus<br />

6715, with a minimum bactericidal c<strong>on</strong>centrati<strong>on</strong> of 0.488, 0.488 and<br />

1.250 g/l, respectively (23). The antimicrobial activities of h<strong>on</strong>okiol and<br />

magnolol were assayed using the agar diluti<strong>on</strong> method and the minimum<br />

inhibitory c<strong>on</strong>centrati<strong>on</strong> (MIC) was determined for each compound using<br />

a twofold serial diluti<strong>on</strong> assay. The results showed that h<strong>on</strong>okiol and<br />

magnolol have a marked antimicrobial effect (MIC, 25.0 μg/ml) against<br />

Actinobacillus actinomycetemcomitans, Porphyrom<strong>on</strong>as gingivalis, Prevotella<br />

intermedia, Micrococcus luteus and Bacillus subtilis, but were not<br />

active against Shigella flexneii, Staphylococcus epidermidis, Enterobacter<br />

aerogenes, Proteus vulgaris, Escherichia coli and Pseudom<strong>on</strong>as ae<strong>ru</strong>ginosa<br />

(24). An extract of the bark and magnolol inhibited the growth of Helicobacter<br />

pylori in vitro (25).<br />

Anti-gastric ulcer activity<br />

Intragastric administrati<strong>on</strong> of aqueous and methanol extract of the c<strong>ru</strong>de<br />

d<strong>ru</strong>g (400 mg/kg bw) reduced gastric juice secreti<strong>on</strong> and increased the pH<br />

of gastric secreti<strong>on</strong>s in mice pretreated with indometacin (26). Indometa-<br />

171

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!